Descrizione

Quantitative analysis of tumor weight and volume from in vivo prostate cancer xenograft experiments with melatonin administration.

Figure 22

Chart

Source Paper

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.

Clinical and translational medicine (2021)

PMID: 34185414

DOI: 10.1002/ctm2.449

Cite This Figure

![Figure 22: Quantitative analysis of tumor weight and volume from in vivo prostate cancer xenograft experiments with melatonin administration.]()

> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)

<figure>
  <img src="" alt="Quantitative analysis of tumor weight and volume from in vivo prostate cancer xenograft experiments with melatonin administration." />
  <figcaption>Figure 22. Quantitative analysis of tumor weight and volume from in vivo prostate cancer xenograft experiments with melatonin administration.<br>  Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption>
</figure>

Evidenze correlate

Melatonin per Disturbo del ritmo circadiano

Grado A · 176 studi